Skip to main content
. 2021 Dec;12(6):2557–2566. doi: 10.21037/jgo-21-503

Table 2. OR for proceeding with surgery for patients treated with chemoradiation with concurrent CAPE or GEM.

Concurrent Chemo Borderline resectable and resectable Borderline resectable only
OR (95% CI) AOR (95% CI) OR (95% CI) AOR (95% CI)
GEM Ref. Ref. Ref. Ref.
CAPE 9.33 (1.50–58.20) 24.75 (1.21–505.13) 7.00 (1.10–44.61) 25.34 (1.14–563.72)

AOR is adjusted by year of diagnosis, weeks of neoadjuvant chemotherapy, and type of neoadjuvant chemotherapy. OR, odd ratios; CAPE, capecitabine; GEM, gemcitabine; Chemo, chemotherapy; CI, confidence interval; AOR, adjusted odd ratios.